SCHEMBL27179907

SCHEMBL27179907

CCN(CC)C(=O)c1cccc(S(=O)(=O)Nc2ccc(Br)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.64
▸ KMT2A Q03164 5/20 0.64
▸ ADORA3 P0DMS8 1/20 0.64
▸ SLC6A3 Q01959 1/20 0.64
▸ PKM P14618 2/20 0.58
▸ RAB9A P51151 1/20 0.58
▸ BRD4 O60885 1/20 0.54
▸ PGR P06401 1/20 0.53
▸ MAPT P10636 3/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ ALOX12 P18054 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ HDAC2 Q92769 1/20 0.51
▸ HDAC8 Q9BY41 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ LIMK1 P53667 1/20 0.51
▸ LIMK2 P53671 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30926954 1.00 MEN1 (0.64) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27179721 0.86 MEN1 (0.68) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30926666 0.86 MEN1 (0.68) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30927008 0.82 MEN1 (0.52) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27180747 0.82 MEN1 (0.52) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27180718 0.82 MEN1 (0.62) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30926985 0.82 MEN1 (0.62) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27180940 0.81 KMT2A (0.73) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30926677 0.81 KMT2A (0.73) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL4253424 0.80 MEN1 (0.79) MEN1KMT2AADORA3SLC6A3PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885ADORA3 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback